Jump to content

Joel Habener

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Grimes2 (talk | contribs) at 09:48, 27 June 2021 (Changing short description from "professor" to "Medical researcher" (Shortdesc helper)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Joel Habener is a Professor of Medicine at Harvard Medical School who has done fundamental studies on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). For his discoveries, he was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[1] He was elected to the National Academy of Sciences in 2020.[2] In 2021 he was awarded the Canada Gairdner International Award.[3]

References

  1. ^ "Prize Recipients | Warren Alpert Foundation Prize". warrenalpert.org.
  2. ^ "2020 NAS Election". www.nasonline.org.
  3. ^ Canada Gairdner International Award 2021


Flag of United StatesScientist icon

This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Joel_Habener&oldid=1030661760"